Did you see News on Streetinsider by MKM partners LeCroy--Telling his Clients--that Stock should go to 20$ after NCE,then BUYOUT in mid 20's.
LeCroy told his clients one month ago-when stock dropped to 11.50$/share to BUY Sept.13 calls and Sell Sept.18 calls (to reduce cost of options). He was right 100%-His clients and others made money .
Kaylawa , Thanks as always .
What do you think about this price action ? It seams very strange to me . With all the great news lately. I would have thought a move into the 16 17 dollar range would have been the norm.
Feels like it wants to but we'll probably see a Form 4 explaining this AM's action. I rarely get interested by daily price action but I *think* we close green. FWIW. I'd love to see Raj from Aegis weigh in with an update. One of the few analysts that knows biopharma intimately.